BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2085596)

  • 1. Pathophysiology of ultrafiltration in peritoneal dialysis.
    Ronco C; Feriani M; Chiaramonte S; Brendolan A; Bragantini L; Conz P; Dell'Aquila R; Milan M; La Greca G
    Perit Dial Int; 1990; 10(2):119-26. PubMed ID: 2085596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
    Sobiecka D; Waniewski J; Weryński A; Lindholm B
    Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual peritoneal dialysis modality prescription in children.
    Fischbach M; Lahlou A; Eyer D; Desprez P; Geisert J
    Perit Dial Int; 1996; 16 Suppl 1():S557-60. PubMed ID: 8728270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B; Zakaria el-R ; Carlsson O
    Perit Dial Int; 1996; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluid and solute transport in CAPD patients before and after permanent loss of ultrafiltration capacity.
    Waniewski J; Sobiecka D; Debowska M; Heimbürger O; Weryński A; Lindholm B
    Int J Artif Organs; 2005 Oct; 28(10):976-86. PubMed ID: 16288435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children.
    Fischbach M; Desprez P; Terzic J; Lahlou A; Mengus L; Geisert J
    Clin Nephrol; 1996 Jul; 46(1):14-6. PubMed ID: 8832143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.
    Heimbürger O; Waniewski J; Werynski A; Tranaeus A; Lindholm B
    Kidney Int; 1990 Sep; 38(3):495-506. PubMed ID: 2232493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.
    Nolph KD; Miller FN; Pyle WK; Popovich RP; Sorkin MI
    Kidney Int; 1981 Nov; 20(5):543-8. PubMed ID: 7343705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of the interstitium in peritoneal transport.
    Flessner MF
    Perit Dial Int; 1996; 16 Suppl 1():S76-9. PubMed ID: 8728167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach.
    Stachowska-Pietka J; Waniewski J; Flessner MF; Lindholm B
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1331-41. PubMed ID: 22301624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
    Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ultrafiltration failure.
    Korbet SM
    Adv Ren Replace Ther; 1998 Jul; 5(3):194-204. PubMed ID: 9686630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis.
    Rosengren BI; Carlsson O; Rippe B
    Am J Kidney Dis; 2001 Jun; 37(6):1277-85. PubMed ID: 11382699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C
    Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the physiology of peritoneal fluid transport.
    Krediet RT; Coester AM; Parikova A; Smit W; Struijk DG
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S144-9. PubMed ID: 18552245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation and management of ultrafiltration failure in CAPD.
    Mactier RA
    Adv Perit Dial; 1991; 7():57-62. PubMed ID: 1680458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.